|
29/10/2021 |
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. |
CIGB |
Registered |
|
01/02/2016 |
CIGB-370 in patients with malignant tumors |
CIGB |
Registered |
|
10/11/2021 |
Expanded Clinical Use of Nasalferon in COVID-19 |
CIGB |
Registered outdated |
|
12/11/2021 |
Nasalferon in COVID-19 |
CIGB |
Registered |
|
27/05/2016 |
COURAGE Study |
CIGB |
Registered |
|
05/01/2017 |
HEBERFERON in renal cell carcinoma |
CIGB |
Registered outdated |
|
30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered outdated |
|
26/01/2017 |
ESAR-814 Study |
CIGB |
Registered |
|
16/02/2017 |
CENTAURO-6 Study |
CIGB |
Registered |
|
03/05/2020 |
Pharmacodynamics of the Nasalferon in healthy volunteers. |
CIGB |
Registered |
|
06/08/2020 |
Transfer factor in Chronic Kidney Disease |
CIGB |
Registered outdated |
|
30/04/2017 |
HEBERBIOVAC HB vaccine to reference material. |
CIGB |
Registered |
|
03/08/2018 |
HeberNasvac® Phase IV in Chronic Hepatitis B |
CIGB |
Registered outdated |
|
22/10/2018 |
DENIS Study |
CIGB |
Registered outdated |
|
23/03/2020 |
EGF in bilateral symmetric diabetic neuropathy |
CIGB |
Registered outdated |
|
07/08/2018 |
AMIGOS-2 study |
CIGB |
Registered outdated |
|
07/08/2018 |
CERVICONC-II-300 study |
CIGB |
Registered outdated |
|
14/10/2022 |
Jusvinza in Severe Patients with Acquired Community Pneumonia |
CIGB |
Registered |
|
14/03/2019 |
COURAGE-2 Study |
CIGB |
Registered outdated |
|
28/05/2020 |
ATENEA-Co-300 study |
CIGB |
Registered outdated |
